Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis.
PloS one(2022)
Abstract
We suggest that urologic malignancies in renal transplant recipients can be investigated for transplant origin. In addition to conventional therapy the allograft immune response against these tumours can be valuable to treat donor-derived cancers.
MoreTranslated text
Key words
urologic cancers,renal transplantation,donor-derived,non-randomized
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined